sodium phosphates

Generic: sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name sodium phosphates
Generic Name sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous
Labeler fresenius kabi usa, llc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

sodium phosphate, dibasic, anhydrous 142 mg/mL, sodium phosphate, monobasic, monohydrate 276 mg/mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 63323-886
Product ID 63323-886_3ae3c9a3-3503-4264-8c77-00089f50cc74
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209997
Listing Expiration 2026-12-31
Marketing Start 2022-03-30

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63323886
Hyphenated Format 63323-886

Supplemental Identifiers

RxCUI
1872384 1872443 1872447
UNII
22ADO53M6F 593YOG76RN

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sodium phosphates (source: ndc)
Generic Name sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous (source: ndc)
Application Number ANDA209997 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 142 mg/mL
  • 276 mg/mL
source: ndc
Packaging
  • 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-886-56) / 50 mL in 1 VIAL, SINGLE-DOSE (63323-886-01)
source: ndc

Packages (1)

63323-886-56 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-886-56) / 50 mL in 1 VIAL, SINGLE-DOSE (63323-886-01)

Ingredients (2)

sodium phosphate, dibasic, anhydrous (142 mg/mL) sodium phosphate, monobasic, monohydrate (276 mg/mL)

Linked Drug Pages (1)

Sodium Phosphates ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "3ae3c9a3-3503-4264-8c77-00089f50cc74", "openfda": {"unii": ["22ADO53M6F", "593YOG76RN"], "rxcui": ["1872384", "1872443", "1872447"], "spl_set_id": ["5bf47be3-f3fe-452b-8113-941796498345"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 TRAY (63323-886-56)  / 50 mL in 1 VIAL, SINGLE-DOSE (63323-886-01)", "package_ndc": "63323-886-56", "marketing_start_date": "20220330"}], "brand_name": "Sodium Phosphates", "product_id": "63323-886_3ae3c9a3-3503-4264-8c77-00089f50cc74", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]"], "product_ndc": "63323-886", "generic_name": "sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sodium Phosphates", "active_ingredients": [{"name": "SODIUM PHOSPHATE, DIBASIC, ANHYDROUS", "strength": "142 mg/mL"}, {"name": "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE", "strength": "276 mg/mL"}], "application_number": "ANDA209997", "marketing_category": "ANDA", "marketing_start_date": "20220330", "listing_expiration_date": "20261231"}